TY - STD TI - Non-small cell lung cancer. National Comprehensive Cancer Network, Guidelines Version 2; 2014. www.nccn.org. UR - http://www.nccn.org ID - ref1 ER - TY - JOUR AU - Wind, J. AU - Smit, E. J. AU - Senan, S. AU - Eerenberg, J. P. PY - 2007 DA - 2007// TI - Residual disease at the bronchial stump after curative resection for lung cancer JO - Eur J Cardiothorac Surg VL - 32 UR - https://doi.org/10.1016/j.ejcts.2007.04.003 DO - 10.1016/j.ejcts.2007.04.003 ID - Wind2007 ER - TY - JOUR AU - Liewald, F. AU - Hatz, R. A. AU - Dienemann, H. AU - Sunder-Plassmann, L. PY - 1992 DA - 1992// TI - Importance of microscopic residual disease at the bronchial margin after resection for non-small-cell carcinoma of the lung JO - J Thorac Cardiovasc Surg VL - 104 ID - Liewald1992 ER - TY - JOUR AU - Snijder, R. J. AU - Brutel de la Riviere, A. AU - Elbers, H. J. J. AU - van der Bosch, J. M. M. PY - 1998 DA - 1998// TI - Survival in resected stage I lung cancer with residual tumor at the bronchial resection margin JO - Ann Thorac Surg VL - 65 UR - https://doi.org/10.1016/S0003-4975(97)01114-4 DO - 10.1016/S0003-4975(97)01114-4 ID - Snijder1998 ER - TY - JOUR AU - Ghiribelli, C. AU - Voltolini, L. AU - Paladini, P. AU - Luzzi, L. AU - Bisceglie, M. AU - Gotti, G. PY - 1999 DA - 1999// TI - Treatment and survival after lung resection for non-small cell lung cancer in patients with microscopic residual disease at the bronchial stump JO - Eur J Cardiothorac Surg VL - 16 UR - https://doi.org/10.1016/S1010-7940(99)00310-3 DO - 10.1016/S1010-7940(99)00310-3 ID - Ghiribelli1999 ER - TY - JOUR AU - Kimura, H. AU - Yamaguchi, Y. PY - 1994 DA - 1994// TI - Survival of noncuratively resected lung cancer JO - Lung Cancer VL - 11 UR - https://doi.org/10.1016/0169-5002(94)90543-6 DO - 10.1016/0169-5002(94)90543-6 ID - Kimura1994 ER - TY - JOUR AU - Massard, G. AU - Doddoli, C. AU - Gasser, B. AU - Durcrocq, X. AU - Kessler, R. AU - Schumacher, C. PY - 2000 DA - 2000// TI - Prognostic implications of a positive bronchial resection margin JO - Eur J Cardiothorac Surg VL - 17 UR - https://doi.org/10.1016/S1010-7940(00)00384-5 DO - 10.1016/S1010-7940(00)00384-5 ID - Massard2000 ER - TY - JOUR AU - Hofmann, H. S. AU - Taege, C. AU - Lautenschlager, C. AU - Neef, H. AU - Silber, R. E. PY - 2002 DA - 2002// TI - Microscopic (R1) and macroscopic (R2) residual disease in patients with resected non-small cell lung cancer JO - Eur J Cardiothorac Surg VL - 21 UR - https://doi.org/10.1016/S1010-7940(02)00030-1 DO - 10.1016/S1010-7940(02)00030-1 ID - Hofmann2002 ER - TY - JOUR AU - Lacasse, Y. AU - Bucher, H. C. AU - Wong, E. AU - Griffith, L. AU - Walter, S. AU - Ginsberg, R. J. PY - 1998 DA - 1998// TI - Incomplete resection in non-small cell lung cancer: need for a new definition JO - Ann Thorac Surg VL - 65 UR - https://doi.org/10.1016/S0003-4975(97)01190-9 DO - 10.1016/S0003-4975(97)01190-9 ID - Lacasse1998 ER - TY - BOOK PY - 2002 DA - 2002// TI - American Joint Committee on Cancer PB - Springer CY - New York ID - ref10 ER - TY - JOUR AU - Mountain, C. F. AU - Dresler, C. M. PY - 1997 DA - 1997// TI - Regional lymph node classification for lung cancer staging JO - Chest VL - 111 UR - https://doi.org/10.1378/chest.111.6.1718 DO - 10.1378/chest.111.6.1718 ID - Mountain1997 ER - TY - STD TI - Common Toxicity Criteria version 3.0. National Cancer Institute. http://ctep.cancer.gov/reporting/ctc.html. UR - http://ctep.cancer.gov/reporting/ctc.html ID - ref12 ER - TY - JOUR AU - Albain, K. S. AU - Crowley, J. J. AU - Turrisi, A. T. AU - Gandara, D. R. AU - Farrar, W. B. AU - Clark, J. I. PY - 2002 DA - 2002// TI - Concurrent cisplatin, etoposide, and chest radiotherapy in pathologic stage IIIB non–small-cell lung cancer: a Southwest Oncology Group phase II study, SWOG 9019 JO - J Clin Oncol VL - 20 UR - https://doi.org/10.1200/JCO.2002.03.055 DO - 10.1200/JCO.2002.03.055 ID - Albain2002 ER - TY - JOUR AU - Curran, W. J. AU - Paulus, R. AU - Langer, C. J. AU - Komaki, R. AU - Lee, J. S. AU - Hauser, S. PY - 2011 DA - 2011// TI - Sequential vs concurrent chemoradiation for stage III non-small cell lung cancer: randomized phase III trial RTOG 9410 JO - J Natl Cancer Inst VL - 103 UR - https://doi.org/10.1093/jnci/djr325 DO - 10.1093/jnci/djr325 ID - Curran2011 ER - TY - JOUR AU - Belani, C. P. AU - Choy, H. AU - Bonomi, P. AU - Scott, C. AU - Travis, P. AU - Haluschak, J. PY - 2005 DA - 2005// TI - Combined chemoradiotherapy regimens of paclitaxel and carboplatin for locally advanced non-small-cell lung cancer: a randomized phase II locally advanced multi-modality protocol JO - J Clin Oncol VL - 23 UR - https://doi.org/10.1200/JCO.2005.55.405 DO - 10.1200/JCO.2005.55.405 ID - Belani2005 ER - TY - JOUR AU - Jeremic, B. AU - Bamberg, M. PY - 2002 DA - 2002// TI - External beam radiation therapy for bronchial stump recurrence of non-small-cell lung cancer after complete resection JO - Radiother Oncol VL - 64 UR - https://doi.org/10.1016/S0167-8140(02)00023-3 DO - 10.1016/S0167-8140(02)00023-3 ID - Jeremic2002 ER - TY - JOUR AU - Bar, J. AU - Ng, D. AU - Moretto, P. AU - Goss, G. D. AU - Sun, A. AU - MacRae, R. PY - 2013 DA - 2013// TI - Chemoradiotherapy for locoregional recurrence of non-small-cell lung cancer after surgical resection: a retrospective analysis JO - Clin Lung Cancer VL - 14 UR - https://doi.org/10.1016/j.cllc.2012.05.008 DO - 10.1016/j.cllc.2012.05.008 ID - Bar2013 ER - TY - JOUR AU - Rodrigues, G. AU - Lock, M. AU - Souza, D. D. AU - Yu, E. AU - Dyk, J. PY - 2004 DA - 2004// TI - Prediction of radiation pneumonitis by dose-volume histogram parameters in lung cancer-a systematic review JO - Radiother Oncol VL - 71 UR - https://doi.org/10.1016/j.radonc.2004.02.015 DO - 10.1016/j.radonc.2004.02.015 ID - Rodrigues2004 ER - TY - JOUR AU - Senan, S. AU - Ruysscher, D. D. AU - Giraud, P. AU - Mirimanoff, R. AU - Budach, V. PY - 2004 DA - 2004// TI - Literature-based recommendations for treatment planning and execution in high-dose radiotherapy for lung cancer JO - Radiother Oncol VL - 71 UR - https://doi.org/10.1016/j.radonc.2003.09.007 DO - 10.1016/j.radonc.2003.09.007 ID - Senan2004 ER - TY - JOUR AU - Uno, T. AU - Isobe, K. AU - Kawakami, H. AU - Ueno, N. AU - Kawata, T. AU - Yamamoto, S. PY - 2006 DA - 2006// TI - Dose-volume factors predicting radiation pneumonitis in patients receiving salvage radiotherapy for postlobectomy locoregional recurrent non-small-cell lung cancer JO - Int J Clin Oncol VL - 11 UR - https://doi.org/10.1007/s10147-005-0542-5 DO - 10.1007/s10147-005-0542-5 ID - Uno2006 ER - TY - JOUR AU - Griess, D. F. AU - McDonald, J. R. AU - Clagett, O. T. PY - 1945 DA - 1945// TI - The proximal extension of carcinoma of the lung in the bronchial wall JO - J Thorac Surg VL - 14 ID - Griess1945 ER - TY - JOUR AU - Cotton, R. E. PY - 1959 DA - 1959// TI - The bronchial spread of lung cancer JO - Br J Dis Chest VL - 53 UR - https://doi.org/10.1016/S0007-0971(59)80004-8 DO - 10.1016/S0007-0971(59)80004-8 ID - Cotton1959 ER - TY - JOUR AU - Olszyna-Serementa, M. AU - Socha, J. AU - Wierzchowski, M. AU - Kepka, L. PY - 2013 DA - 2013// TI - Patterns of failure after postoperative radiotherapy for incompletely resected (R1) non-small cell lung cancer: Implications for radiation target volume design JO - Lung Cancer VL - 80 UR - https://doi.org/10.1016/j.lungcan.2013.01.010 DO - 10.1016/j.lungcan.2013.01.010 ID - Olszyna-Serementa2013 ER - TY - JOUR AU - Hanna, N. AU - Shepherd, F. A. AU - Fossella, F. V. AU - Pereira, J. R. AU - Marinis, F. D. AU - Pawel, J. PY - 2004 DA - 2004// TI - Randomized phase III trial of pemetrexed versus docetaxel in patients with non-small-cell lung cancer previously treated with chemotherapy JO - J Clin Oncol VL - 22 UR - https://doi.org/10.1200/JCO.2004.08.163 DO - 10.1200/JCO.2004.08.163 ID - Hanna2004 ER - TY - JOUR AU - Scagliotti, G. AU - Parikh, P. AU - Pawel, J. AU - Biesma, B. AU - Vansteenkiste, J. AU - Manegold, C. PY - 2008 DA - 2008// TI - Phase III study comparing cisplatin plus gemcitabine with cisplatin plus pemetrexed in chemotherapy-naive patients with advanced-stage non-small-cell lung cancer JO - J Clin Oncol VL - 26 UR - https://doi.org/10.1200/JCO.2007.15.0375 DO - 10.1200/JCO.2007.15.0375 ID - Scagliotti2008 ER - TY - JOUR AU - Mok, T. S. AU - Wu, Y. L. AU - Thongprasert, S. AU - Yang, C. H. AU - Chu, D. T. AU - Saijo, N. PY - 2009 DA - 2009// TI - Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma JO - N Engl J Med VL - 361 UR - https://doi.org/10.1056/NEJMoa0810699 DO - 10.1056/NEJMoa0810699 ID - Mok2009 ER - TY - JOUR AU - Zhou, C. AU - Wu, Y. L. AU - Chen, G. AU - Feng, J. AU - Liu, X. Q. AU - Wang, C. PY - 2011 DA - 2011// TI - Erlotinib versus chemotherapy as first-line treatment for patients with advanced EGFR mutation-positive non-small-cell lung cancer (OPTIMAL, CTONG-0802): a multicentre, open-label, randomised, phase 3 study JO - Lancet Oncol VL - 12 UR - https://doi.org/10.1016/S1470-2045(11)70184-X DO - 10.1016/S1470-2045(11)70184-X ID - Zhou2011 ER -